SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Documents Incorporated by Reference in ‘S-3’ Filing 1193125-21-41411 · Filed re: Thursday, 6/19/08
19
JUN


        

11  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
 6/27/08  Woodthorpe Katherine              3          Director²   2:7K   EyePoint Pharmaceuticals, Inc.    R R Donnelley … Filer/FA 
 6/27/08  Soja Michael                      3          Officer²    2:10K  EyePoint Pharmaceuticals, Inc.    R R Donnelley … Filer/FA 
 6/27/08  Mazzo David J                     3          Director²   2:8K   EyePoint Pharmaceuticals, Inc.    R R Donnelley … Filer/FA 
 6/27/08  Rogers Michael W                  3          Director²   2:8K   EyePoint Pharmaceuticals, Inc.    R R Donnelley … Filer/FA 
 6/27/08  Freedman Lori                     3          Officer²    1:7K   EyePoint Pharmaceuticals, Inc.    R R Donnelley … Filer/FA 
 6/27/08  Ashton Paul                       3          Dir.,Off.²  2:10K  EyePoint Pharmaceuticals, Inc.    R R Donnelley … Filer/FA 
 6/24/08  EyePoint Pharmaceuticals, Inc.    8-K:3       6/19/08    1:12K                                    Donnelley … Solutions/FA 
 6/20/08 EyePoint Pharmaceuticals, Inc.    POS AM                 3:232K                                   Donnelley … Solutions/FA 
 6/20/08EyePoint Pharmaceuticals, Inc.    POS AM                 3:240K                                   Donnelley … Solutions/FA 
 6/20/08EyePoint Pharmaceuticals, Inc.    8-K:8,9     6/19/08    2:2M                                     Donnelley … Solutions/FA 
 6/19/08  EyePoint Pharmaceuticals, Inc.    8-K12G3:8,9 6/19/08    4:576K                                   Donnelley … Solutions/FA 
____________
 ‡  A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm
Five-thirty emoji
ET
.  The legal “Filed As Of” date may be the next, or another, day.
 ¹  Filing/Form Types: 
Type emoji
  3    Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
  8-K    Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
  8-K12G3    Notice of Securities Deemed to be Registered by a Successor Issuer — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
  POS AM    Post-Effective Amendment of a Registration Statement.
 ²  Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 10:21:01.3am ET